Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaowen Jiang

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cell|December 28, 2021
EMSY inhibits homologous recombination repair and the interferon response, promoting lung cancer immune evasionAntonio Marzio, Emma Kurz, Jennifer M Sahni, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 26, 2026
A temporal and spatial atlas of adaptive immune responses in the lymph node following viral infectionShaowen Jiang, Jahanara Freedman, Madhav Mantri, et al.
Journal of Gastroenterology and Hepatology|August 23, 2016
Persistently elevated circulating Th22 reversely correlates with prognosis in HBV-related acute-on-chronic liver failureRuidong Mo, Peng Wang, Rongtao Lai, et al.
Hepatology International|May 15, 2023
Clinic-radiomics model using liver magnetic resonance imaging helps predict chronicity of drug-induced liver injuryHaoshuang Fu, Zhehan Shen, Rongtao Lai, et al.
Theranostics|August 22, 2018
Enhanced autophagy contributes to protective effects of IL-22 against acetaminophen-induced liver injuryRuidong Mo, Rongtao Lai, Jie Lu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 18, 2019
The impact of HBV flare on the outcome of HBV-related decompensated cirrhosis patients with bacterial infectionZhujun Cao, Yuhan Liu, Shijin Wang, et al.
Nature|April 15, 2021
CRL4<sup>AMBRA1</sup> is a master regulator of D-type cyclinsDaniele Simoneschi, Gergely Rona, Nan Zhou, et al.
Gut|November 6, 2025
HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER)Edo J Dongelmans, Lesley A Patmore, Seng Gee Lim, et al.
Cancer Discovery|December 16, 2021
Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast CancerChewei Anderson Chang, Jayu Jen, Shaowen Jiang, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cell|December 28, 2021
EMSY inhibits homologous recombination repair and the interferon response, promoting lung cancer immune evasionAntonio Marzio, Emma Kurz, Jennifer M Sahni, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 26, 2026
A temporal and spatial atlas of adaptive immune responses in the lymph node following viral infectionShaowen Jiang, Jahanara Freedman, Madhav Mantri, et al.
Journal of Gastroenterology and Hepatology|August 23, 2016
Persistently elevated circulating Th22 reversely correlates with prognosis in HBV-related acute-on-chronic liver failureRuidong Mo, Peng Wang, Rongtao Lai, et al.
Hepatology International|May 15, 2023
Clinic-radiomics model using liver magnetic resonance imaging helps predict chronicity of drug-induced liver injuryHaoshuang Fu, Zhehan Shen, Rongtao Lai, et al.
Theranostics|August 22, 2018
Enhanced autophagy contributes to protective effects of IL-22 against acetaminophen-induced liver injuryRuidong Mo, Rongtao Lai, Jie Lu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 18, 2019
The impact of HBV flare on the outcome of HBV-related decompensated cirrhosis patients with bacterial infectionZhujun Cao, Yuhan Liu, Shijin Wang, et al.
Nature|April 15, 2021
CRL4<sup>AMBRA1</sup> is a master regulator of D-type cyclinsDaniele Simoneschi, Gergely Rona, Nan Zhou, et al.
Gut|November 6, 2025
HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER)Edo J Dongelmans, Lesley A Patmore, Seng Gee Lim, et al.
Cancer Discovery|December 16, 2021
Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast CancerChewei Anderson Chang, Jayu Jen, Shaowen Jiang, et al.
Pageof 2